Music Therapy + Brain Stimulation for Corticobasal Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how music therapy and gentle brain stimulation might help individuals with corticobasal syndrome (CBS) improve arm and hand use. Participants will either engage in exercises with music, such as Patterned Sensory Enhancement (PSE), or combine these exercises with brain stimulation, specifically Transcranial Direct Current Stimulation (tDCS), to determine which method is more effective. The trial aims to assess whether these approaches can enhance daily function and overall quality of life for CBS patients. Eligible participants should have CBS, be right-handed, and not have conditions like migraines or metal implants. As an unphased trial, this study provides a unique opportunity to explore innovative therapies that could improve daily life for CBS patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study coordinators or your doctor.
What prior data suggests that these interventions are safe for patients with corticobasal syndrome?
Research has shown that Patterned Sensory Enhancement (PSE), a type of music therapy, is generally safe and may improve movement across various groups. A review on PSE suggests it could enhance movement abilities without major issues reported. So far, studies have not identified any serious side effects.
For Transcranial Direct Current Stimulation (tDCS), evidence indicates it is well-tolerated. Many studies have reported no serious side effects, with the most common minor issue being skin irritation where the device contacts the skin. Overall, previous research has found both PSE and tDCS treatments to be safe.12345Why are researchers excited about this trial?
Researchers are excited about combining Music Therapy and Brain Stimulation for Corticobasal Syndrome because these techniques offer unique benefits compared to existing treatments. Standard treatments often focus on managing symptoms with medications like levodopa or physical therapies. However, Patterned Sensory Enhancement (PSE) uses musical cues to stimulate movement and emotional responses, potentially enhancing motor skills and emotional well-being. Transcranial Direct Current Stimulation (tDCS) is another innovative approach that non-invasively modulates brain activity to improve cognitive and motor functions. Together, these methods offer a fresh perspective by targeting both the brain's electrical activity and the emotional-motor connection through music, which might lead to more holistic improvements for patients.
What evidence suggests that these treatments could be effective for corticobasal syndrome?
Studies have shown that music-based treatments like Patterned Sensory Enhancement (PSE) can improve hand and arm movements, particularly in conditions like Parkinson's disease, where rhythmic cues aid movement. In this trial, one group of participants will receive only PSE, while another group will receive a combination of PSE with transcranial direct current stimulation (tDCS), a gentle brain stimulation method. Research suggests that this combination can further enhance arm and hand function in various diseases. Early findings in corticobasal syndrome (CBS) showed that tDCS alone improved thinking skills, such as reaction time during tasks. Overall, these methods might offer promising ways to improve movement and thinking abilities in CBS patients.15678
Who Is on the Research Team?
Alexander Pantelyat, MD
Principal Investigator
Department of Neurology, Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for right-handed individuals aged 18-89 with corticobasal syndrome (CBS). It's not suitable for those with a history of seizures, skin conditions like psoriasis or eczema, psychological/neurological disorders, pregnancy, inability to follow study procedures, adverse reactions to brain stimulation techniques, migraines, metallic implants including pacemakers or past significant head injuries.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either PSE or PSE+tDCS interventions, 30 minutes per session, twice a week for three weeks
Follow-up
Participants are monitored for changes in upper extremity performance and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Patterned Sensory Enhancement (PSE)
- Transcranial Direct Current Stimulation (tDCS)
Patterned Sensory Enhancement (PSE) is already approved in United States, European Union for the following indications:
- Rehabilitation for upper extremity motor function in patients with corticobasal syndrome (CBS) and stroke
- Rehabilitation for upper extremity motor function in patients with stroke and neurodegenerative disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor